Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Recruiting Phase 1 Trials for Osimertinib (DB09330)

IndicationStatusPhase
DBCOND0115716 (Stage IIIB Lung Non-Small Cell Cancer AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs